Guyana vs Indonesia: Cause of death, by non-communicable diseases, ages 15-59, female
Guyana
53.6%
in 2021
Indonesia
53.8%
in 2021
Guyana rank
119th
Indonesia rank
118th
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Guyana
- Indonesia
How they compare
Indonesia currently reports 53.8% against 53.6% in Guyana, a difference of 0.2%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Indonesia ahead.
Guyana ranks 119th and Indonesia ranks 118th of 185 countries.
Across the 3 decades both report, Guyana averaged higher in 1 and Indonesia in 2.
Head to head by decade
| Decade | Guyana | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 63.6% | 67.6% | 4.1% | Indonesia |
| 2010s | 66.4% | 76.1% | 9.7% | Indonesia |
| 2020s | 59.6% | 59.4% | 0.3% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Guyana or Indonesia?
- Indonesia, at 53.8% against 53.6% in Guyana as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Guyana and Indonesia?
- 0.2%, with Indonesia ahead.
- How many years of comparable data are there for Guyana and Indonesia?
- 6 years are reported by both, from 2000 to 2021.
- How do Guyana and Indonesia rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Guyana ranks 119th and Indonesia ranks 118th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.